Peripheral manifestations of spondyloarthritis in Guinea

##plugins.themes.academic_pro.article.sidebar##

Published Nov 6, 2023
Download
pdf
Vol. 101 No. 8-9 (2023): Tunis med aug-sept 2023

##plugins.themes.academic_pro.article.main##

Kaba Conde
Department of Rheumatology, Ignace Deen University Hospital, Conakry, Guinea
Morézik Salifou
Department of Rheumatology, Ignace Deen University Hospital, Conakry, Guinea
Abdoulaye Barry
Department of Rheumatology, Ignace Deen University Hospital, Conakry, Guinea
Florent Adjakou
Department of Rheumatology, Ignace Deen University Hospital, Conakry, Guinea
Moriba Touré
Department of Rheumatology, Ignace Deen University Hospital, Conakry, Guinea
Aly Badra Kamissoko
Department of Rheumatology, Ignace Deen University Hospital, Conakry, Guinea
Fodé Abass Cissé
Department of Neurology, Ignace Deen University Hospital, Conakry, Guinea

Abstract

Introduction: SpA is a group of chronic inflammatory rheumatic diseases that mainly affect the axial skeleton, but may also associate peripheral manifestations such as arthritis, enthesitis and dactylitis.


Aim : Describe the peripheral manifestations of SpA.


Methods: We conducted a descriptive cross-sectional study of SpA patients received at the rheumatology department of CHU Ignace Deen in Conakry over a one-year period from June 1, 2021 to May 31, 2022. The diagnosis of SpA was retained in accordance with the ASAS (Assessment of spondyloarthritis internationnal society) classification and data on peripheral manifestations were collected.


Results: A total of 275 patients met the criteria and 82 had at least one peripheral involvement (29.8%). The mean age was 52.3 years, with females predominating in 58 (70.5%) cases. The mean time to diagnosis was 11 years. The most frequent peripheral manifestation was peripheral joint involvement (78%), followed by peripheral enthesitis (36.6%). The predominant clinical form was axial in 51.2%, with HLA-B27 antigen present in 63% and sacroiliitis in 51.2%. Treatment was based on NSAIDs (67.1%).


Conclusion: Peripheral manifestations are becoming increasingly frequent in SpA, and are dominated by peripheral joint involvement. The predominant clinical form was axial, with a strong association with HLA-B27.

Keywords:

Spondyloarthritis, peripherals manifestations, Guinea

##plugins.themes.academic_pro.article.details##

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

References

  1. Molto A, Sieper J. Peripheral spondyloarthritis: Concept, diagnosis and treatment. Best Practice & Research Clinical Rheumatology 2018;32:357–68.
  2. Carron P, De Craemer A-S, Van den Bosch F. Peripheral spondyloarthritis: a neglected entity—state of the art. RMD Open 2020;6:001136.
  3. López-Medina C, Moltó A, Dougados M. Peripheral Manifestations in Spondyloarthritis and their Effect: An Ancillary Analysis of the ASAS-COMOSPA Study. J Rheumatol 2020;47:211–7.
  4. de Winter JJ, Paramarta JE, de Jong HM, van de Sande MG, Baeten DL. Peripheral disease contributes significantly to the level of disease activity in axial spondyloarthritis. RMD Open 2019;5:000802.
  5. Wendling D, Prati C, Toussirot É, Ornetti P. Spondylarthrite, spondylarthropathies : critères de diagnostic et de classification. Revue du Rhumatisme Monographies 2010;77:43–7.
  6. Smolen JS, Schöls M, Braun J, Dougados M, FitzGerald O, Gladman DD, et al. Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force. Ann Rheum Dis 2018;77:3–17.
  7. Parlier-Cuau C, Touraine S, Laredo J-D. Imagerie des atteintes rhumatismales de la paroi thoracique antérieure. Revue du Rhumatisme Monographies 2015;82:163–9.
  8. Rudwaleit M, van der Heijde D, Landewe R, Akkoc N, Brandt J, Chou CT, et al. The Assessment of SpondyloArthritis international Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Annals of the Rheumatic Diseases 2011;70:25–31.
  9. Reveille JD. Epidemiology of Spondyloarthritis in North America. The American Journal of the Medical Sciences 2011;341:284–6.
  10. Carron P, De Craemer A-S, Van den Bosch F. Peripheral spondyloarthritis: a neglected entity—state of the art. RMD Open 2020;6:001136.
  11. Abba A, Niasse M, Diaby LM, Ali H. Spondyloarthrites au Sénégal : étude de 770 observations Spondyloarthritis in Senegal : a study of 770 cases. Tunis Med 2021;99:8.
  12. Lebughe P, de Vlam K, Westhovens R, Mbuyi-Muamba J-M, Malemba JJ. Spondyloarthritis in the Democratic Republic of the Congo: a prospective hospital-based study. BMJ Open 2018;8:020329.
  13. Wendling PD. Le diagnostic de spondyloarthrite chez le sujet de plus de 50 ans. LE POINT SUR 2015;12:13.
  14. Lesavre A, Miquel A, Pradel C, Tubiana JM, Menu Y. Atteintes peripheriques des spondylarthropathies. Journal de Radiologie 2008;89:1439.
  15. Rudwaleit M, van der Heijde D, Landewe R, Listing J, Akkoc N, Brandt J, et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 2009;68:777–783.
  16. Astier F. La spondylarthrite ankylosante et la place de l’immunothérapie dans son traitement. rev rhum 2012;22:48-52.
  17. Belkhou A, Bakri Y, Yakoubi H, Amine M, Niamane R, Hassani SE. Prévalence du gène HLA B-27 dans la spondylarthrite ankylosante au Maroc. Rev Mar Rhum 2013; 25: 38-41
  18. Dougados M, d’Agostino M-A, Benessiano J, Berenbaum F, Breban M, Claudepierre P, et al. La cohorte DESIR : un suivi à dix ans des lombalgies inflammatoires récentes en France : méthodologie et caractéristiques initiales des 708 patients recrutés. Revue du Rhumatisme 2011;78:446–52.
  19. Ben Radhia K, Ayed-Jendoubi S, Ben Romdhane IST, Makhlouf M, Gorgi Y, Ayed K. Distribution des sous-types HLA-B27 en Tunisie et leur association avec la spondylarthrite ankylosante. Rev Rhuma 2008;75(3):250–253.
  20. Kaba C, Moustapha N, Salissou GM, Rama D, Bamba DCA, Coumba D, et al. Spondyloarthrites au Sénégal: Étude de 350 Observations. ESJ 2019;15.
  21. Bannwarth B. Traitements anti-inflammatoires. Place des AINS classiques et des coxibs. EMC - Médecine 2005;2:524–531.